Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001827672-21-000002

President and CEO sold 5,833 shares at an average $25.25 ($147,301)

From the SEC's structured data for this filing

Trades in this filing

Azamian Bobak R. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-01 Sale : show line 1 in the form −5,733 $25.23 $144,661 1,221,705 I
2021-09-01 Sale : show line 2 in the form −100 $26.40 $2,640 1,221,605 I
Open-market sales · 5,833 sh · avg $25.25 · $147,301
Loading xslF345X03/wf-form4_163070587277035.xml…